Vera Therapeutics (NASDAQ:VERA) Price Target Raised to $85.00 at HC Wainwright
Vera Therapeutics (NASDAQ:VERA – Get Free Report) had its price objective raised by analysts at HC Wainwright from $75.00 to $85.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 174.99% from the company’s previous close. […]
Vera Therapeutics (NASDAQ:VERA – Get Free Report) had its price objective raised by analysts at HC Wainwright from $75.00 to $85.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 174.99% from the company’s previous close. […]
